# US 2026/0248875 A1 · Hydrolyzed collagen for use in reducing blood glucose

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0248875 A1
- Document ID: US20260248875A1
- Status: Published application
- Kind: A1
- Application number: 19/649,860
- Filed: 2026-04-16
- Published: 2026-08-27
- Earliest claimed: 2022-06-02
- Assignees: Rousselot B.V.
- Applicants: Rousselot B.V.
- Inventors: Kristof Robert CALLEMIN; Elien Monique GEVAERT; Arne GOES; Janne PRAWITT; Sara VLEMINCKX
- Web page: https://patentgrep.com/patent/US20260248875A1

## CPC

- A23L 33/18: Peptides; Protein hydrolysates
- A61K 38/014: {from connective tissue peptides, e.g. gelatin, collagen}
- A23L 33/28: Substances of animal origin, e.g. gelatin or collagen
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- C12N 9/485: {Exopeptidases (3.4.11-3.4.19)}
- C12N 9/50: Proteinases {, e.g. Endopeptidases (3.4.21-3.4.25)}
- C12P 21/06: produced by the hydrolysis of a peptide bond, e.g. hydrolysate products (preparing foodstuffs by protein hydrolysis A23J3/00)
- C12Y 304/11001: Leucyl aminopeptidase (3.4.11.1)
- C12Y 304/17001: Carboxypeptidase A (3.4.17.1)
- C12Y 304/24: Metalloendopeptidases (3.4.24)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The present invention relates to a hydrolyzed collagen formulation for use in decreasing blood glucose. The hydrolyzed collagen is obtained by enzymatic hydrolysis of a collagen-containing material with a combination of enzymes comprising two or more enzymes selected from the group consisting of a neutral protease, a carboxypeptidase, and an aminopeptidase. The hydrolyzed collagen formulation is particularly suitable as a food supplement, such as for use in ameliorating hyperglycemia and/or a risk factor hyperglycemia.

## Claims

### Claim at position 1

1-39. (canceled)

### Claim 40

A glucagon-like peptide-1 (GLP-1) secretion-stimulating hydrolyzed collagen, wherein the hydrolyzed collagen:
is obtained by enzymatic hydrolysis of a collagen-containing material with a combination of enzymes comprising a neutral protease and one or both of a carboxypeptidase, and an aminopeptidase; and
has a weight average molecular weight of 2000-4500 Da, or 2500-4000 Da; and
comprises 35-60% by weight of collagen peptides with a molecular weight in the range of 2000-5000 Da, calculated on total weight of collagen peptides in the hydrolyzed collagen; and
is capable of stimulating glucagon-like peptide-1 (GLP-1) secretion in a human subject.

### Claim 41 (depends on 40)

The hydrolyzed collagen according to claim 40, wherein stimulating GLP-1 secretion is in STC-1 cells.

### Claim 42 (depends on 40)

The hydrolyzed collagen according to claim 40, wherein the hydrolyzed collagen is capable of stimulating GLP-1 secretion, defined as an at least 2000-fold increase in GLP-1 secretion by STC-1 cells after stimulation with 10 mg/ml hydrolyzed collagen, relative to stimulation with a blank control.

### Claim 43 (depends on 40)

The hydrolyzed collagen according to claim 40, wherein the hydrolyzed collagen is capable of one or more of:
increasing blood glucagon-like peptide-1;
decreasing blood glucagon;
increasing blood insulin;
increasing blood insulin/glucose ratio;
ameliorating the amount of glucose in the blood after a meal;
ameliorating the peak in glucose in the blood after a meal; or
ameliorating postprandial glucose.

### Claim 44 (depends on 40)

The hydrolyzed collagen according to claim 40, wherein the hydrolyzed collagen has a weight average molecular weight of 2500-3500 Da.

### Claim 45 (depends on 40)

The hydrolyzed collagen according to claim 40, wherein the hydrolyzed collagen is obtained by enzymatic hydrolysis of collagen-containing material with a combination of enzymes comprising a neutral protease, a carboxypeptidase, and aminopeptidase.

### Claim 46 (depends on 40)

The hydrolyzed collagen according to claim 40, wherein the collagen-containing material is gelatin.

### Claim 47 (depends on 40)

The hydrolyzed collagen according to claim 40, wherein the hydrolyzed collagen comprises:
1-20% by weight of collagen peptides with a molecular weight below 1000 Da; and/or
20-40% by weight of collagen peptides with a molecular weight of 1000-2000 Da; and/or
5-25% by weight of collagen peptides with a molecular weight of 5000-10000 Da; and/or
0-10% by weight of collagen peptides with a molecular weight more than 10000 Da, calculated on the total weight of collagen peptides in the hydrolyzed collagen.

### Claim 48

A method for obtaining a hydrolyzed collagen capable of stimulating GLP-1 secretion, the method comprising
a) providing a collagen-containing material in a liquid formulation; and
b) subjecting the collagen-containing material to a combination of enzymes comprising a neutral protease and one or both of carboxypeptidase, and aminopeptidase,
wherein step b) is performed until the hydrolyzed collagen
has a weight average molecular weight of 2000-4500 Da, or 2500-4000 Da; and
comprises 35-60% by weight of collagen peptides with a molecular weight in the range of 2000-5000 Da, calculated on total weight of collagen peptides in the hydrolyzed collagen.

### Claim 49 (depends on 48)

The method according to claim 48, wherein step b) is performed until the hydrolyzed collagen has a weight average molecular weight of 2500-3500 Da.

### Claim 50 (depends on 48)

The method according to claim 48, wherein stimulating GLP-1 secretion is in STC-1 cells.

### Claim 51 (depends on 50)

The method according to claim 50, wherein the hydrolyzed collagen obtained is capable of stimulating GLP-1 secretion, defined as an at least 2000-fold increase in GLP-1 secretion by STC-1 cells after stimulation with 10 mg/ml hydrolyzed collagen, relative to stimulation with a blank control.
